Mario Clerici

42.3k total citations · 9 hit papers
676 papers, 30.0k citations indexed

About

Mario Clerici is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Mario Clerici has authored 676 papers receiving a total of 30.0k indexed citations (citations by other indexed papers that have themselves been cited), including 246 papers in Virology, 228 papers in Immunology and 161 papers in Infectious Diseases. Recurrent topics in Mario Clerici's work include HIV Research and Treatment (239 papers), Immune Cell Function and Interaction (138 papers) and HIV/AIDS Research and Interventions (74 papers). Mario Clerici is often cited by papers focused on HIV Research and Treatment (239 papers), Immune Cell Function and Interaction (138 papers) and HIV/AIDS Research and Interventions (74 papers). Mario Clerici collaborates with scholars based in Italy, United States and Saudi Arabia. Mario Clerici's co-authors include Gene M. Shearer, Daria Trabattoni, G M Shearer, Gene M. Shearer, Manuela Sironi, Rachele Cagliani, Diego Forni, Daniel R. Lucey, Marina Saresella and Mara Biasin and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Mario Clerici

654 papers receiving 29.3k citations

Hit Papers

A TH1→TH2 switch is a critical step in the etiology of HI... 1989 2026 2001 2013 1993 1995 1994 1989 1996 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A TH1→TH2 switch is a critical step in the etiology of HIV infection
    1993 1.2k citations Mario Clerici, Gene M. Shearer profile →
  2. T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
    1995 983 citations Mario Clerici, Gene M. Shearer et al. profile →
  3. The Th1–Th2 hypothesis of HIV infection: new insights
    1994 576 citations Mario Clerici et al. profile →
  4. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging.
    1989 540 citations Mario Clerici et al. profile →
  5. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
    1996 529 citations Mario Clerici et al. profile →
  6. Molecular Evolution of Human Coronavirus Genomes
    2016 505 citations Rachele Cagliani, Mario Clerici et al. profile →
  7. Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection
    1992 402 citations Mario Clerici et al. profile →
  8. Analysis of SARS-CoV-2 vertical transmission during pregnancy
    2020 234 citations Claudio Fenizia, Mara Biasin et al. profile →
  9. UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication
    2021 223 citations Mara Biasin, Andrea Bianco et al. Scientific Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Clerici Italy 83 11.1k 9.6k 6.8k 6.2k 6.2k 676 30.0k
Howard E. Gendelman United States 97 7.8k 0.7× 17.3k 1.8× 8.6k 1.3× 8.5k 1.4× 4.9k 0.8× 495 36.4k
Barton F. Haynes United States 90 16.7k 1.5× 14.9k 1.5× 8.5k 1.2× 8.5k 1.4× 5.7k 0.9× 432 34.7k
H. Clifford Lane United States 77 10.5k 1.0× 12.1k 1.3× 10.0k 1.5× 14.5k 2.3× 7.1k 1.1× 309 42.5k
Frederick Hecht United States 80 5.6k 0.5× 9.6k 1.0× 8.3k 1.2× 4.1k 0.7× 4.6k 0.7× 517 25.1k
James J. Goedert United States 75 8.6k 0.8× 7.4k 0.8× 5.9k 0.9× 5.5k 0.9× 7.6k 1.2× 326 27.0k
David A. Price United Kingdom 92 20.8k 1.9× 10.4k 1.1× 5.5k 0.8× 7.6k 1.2× 6.4k 1.0× 536 38.4k
Alan Landay United States 82 10.0k 0.9× 12.7k 1.3× 9.1k 1.3× 4.1k 0.7× 6.6k 1.1× 525 27.3k
Joseph M. McCune United States 79 9.1k 0.8× 9.6k 1.0× 5.8k 0.9× 3.1k 0.5× 4.2k 0.7× 216 19.4k
Christopher Power Canada 86 8.3k 0.8× 6.2k 0.6× 3.4k 0.5× 6.8k 1.1× 3.2k 0.5× 374 26.0k
Jay A. Levy United States 83 9.1k 0.8× 14.2k 1.5× 8.7k 1.3× 3.1k 0.5× 6.6k 1.1× 306 22.8k

Countries citing papers authored by Mario Clerici

Since Specialization
Citations

This map shows the geographic impact of Mario Clerici's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Clerici with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Clerici more than expected).

Fields of papers citing papers by Mario Clerici

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Clerici. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Clerici. The network helps show where Mario Clerici may publish in the future.

Co-authorship network of co-authors of Mario Clerici

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Clerici. A scholar is included among the top collaborators of Mario Clerici based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Clerici. Mario Clerici is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marzano, Angelo Valerio, Michele Bartoletti, Vincenzo Bettoli, et al.. (2025). Hidradenitis suppurativa, from basic science to surgery and a new era of tailored targeted therapy: An expert opinion paper. Archives of Dermatological Research. 317(1). 511–511. 1 indexed citations
2.
Cappelletti, Gioia, Lorenzo Brambilla, Fiona Limanaqi, et al.. (2025). iPSC ‐derived human cortical organoids display profound alterations of cellular homeostasis following SARS ‐ CoV ‐2 infection and Spike protein exposure. The FASEB Journal. 39(4). e70396–e70396.
3.
Piancone, Federica, Francesca La Rosa, Ambra Hernis, et al.. (2025). Neuroinflammatory Signature of Post-Traumatic Confusional State: The Role of Cytokines in Moderate-to-Severe Traumatic Brain Injury. International Journal of Molecular Sciences. 26(17). 8593–8593. 1 indexed citations
4.
Limanaqi, Fiona, Silvia Zecchini, Irma Saulle, et al.. (2024). Alpha-synuclein dynamics bridge Type-I Interferon response and SARS-CoV-2 replication in peripheral cells. Biological Research. 57(1). 2–2. 8 indexed citations
5.
Rallón, Norma, José M. Benito, Francisco J. Márquez, et al.. (2024). Impact of Human Leukocyte Antigen Allele–Killer Cell Immunoglobulin-like Receptor Partners on Sexually Transmitted Human Immunodeficiency Virus Type 1 Infection. The Journal of Infectious Diseases. 230(5). e1077–e1081.
6.
Sabico, Shaun, Mohammed Ghouse Ahmed Ansari, Abdullah M. Alnaami, et al.. (2023). Differences and Associations of NLRP3 Inflammasome Levels with Interleukins 1α, 1β, 33 and 37 in Adults with Prediabetes and Type 2 Diabetes Mellitus. Biomedicines. 11(5). 1315–1315. 8 indexed citations
7.
Saresella, Marina, C Zoia, Francesca La Rosa, et al.. (2023). Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation. Pharmaceuticals. 16(12). 1725–1725. 6 indexed citations
8.
Rosa, Francesca La, Roberta Mancuso, Simone Agostini, et al.. (2021). Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease. Pharmaceuticals. 14(11). 1187–1187. 16 indexed citations
9.
Biasin, Mara, Andrea Bianco, Giovanni Pareschi, et al.. (2021). UV-C irradiation is highly effective in inactivating SARS-CoV-2 replication. Scientific Reports. 11(1). 6260–6260. 223 indexed citations breakdown →
10.
Torretta, Enrica, Beatrice Arosio, Pietro Barbacini, et al.. (2021). Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF. International Journal of Molecular Sciences. 22(15). 8034–8034. 14 indexed citations
11.
Aguilar-Jiménez, Wbeimar, Wildeman Zapata, Antonio Rivero‐Juárez, et al.. (2019). Genetic associations of the vitamin D and antiviral pathways with natural resistance to HIV-1 infection are influenced by interpopulation variability. Infection Genetics and Evolution. 73. 276–286. 2 indexed citations
12.
Nociti, Viviana, Massimo Santoro, Davide Quaranta, et al.. (2018). BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression. PLoS ONE. 13(10). e0206140–e0206140. 25 indexed citations
13.
Rainone, Veronica, Vania Giacomet, Francesca Penagini, et al.. (2015). Human papilloma virus vaccination induces strong human papilloma virus specific cell-mediated immune responses in HIV-infected adolescents and young adults. AIDS. 29(6). 739–743. 9 indexed citations
14.
Braida, Daniela, Franca Rosa Guerini, Luisa Ponzoni, et al.. (2015). Association between SNAP-25 gene polymorphisms and cognition in autism: functional consequences and potential therapeutic strategies. Translational Psychiatry. 5(1). e500–e500. 74 indexed citations
15.
Saulle, Irma, Mara Biasin, Federica Gnudi, et al.. (2014). Evolutionary Analysis Identifies an MX2 Haplotype Associated with Natural Resistance to HIV-1 Infection. AIDS Research and Human Retroviruses. 30(S1). A24–A25. 1 indexed citations
16.
Boasso, Adriano, Caroline Royle, Mara Biasin, et al.. (2011). Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis. Blood. 118(19). 5152–5162. 39 indexed citations
17.
Altamura, A. Carlo, Emanuela Mundo, Elisabetta Cattaneo, et al.. (2009). The MCP-1 Gene (SCYA2) and Mood Disorders: Preliminary Results of a Case-Control Association Study. NeuroImmunoModulation. 17(2). 126–131. 30 indexed citations
18.
Fumagalli, Matteo, Uberto Pozzoli, Rachele Cagliani, et al.. (2009). Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. The Journal of Experimental Medicine. 206(6). 1395–1408. 188 indexed citations
19.
Gori, Andrea, Camilla Tincati, Giuliano Rizzardini, et al.. (2007). Early Impairment of Gut Function and Gut Flora Supporting a Role for Alteration of Gastrointestinal Mucosa in Human Immunodeficiency Virus Pathogenesis. Journal of Clinical Microbiology. 46(2). 757–758. 164 indexed citations
20.
Hernandez, Diana, Michael R. Betts, Mario Clerici, et al.. (1992). Brucella abortus Stimulates Human T Cells from Uninfected and HIV-infected Individuals to Secrete IFNγ: Implications for Use of Brucella abortus as a Carrier in Development of Human Vaccines. AIDS Research and Human Retroviruses. 8(4). 479–486. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Howard E. Gendelman Breakdown of academic impact, for papers by Barton F. Haynes Breakdown of academic impact, for papers by H. Clifford Lane Breakdown of academic impact, for papers by Frederick Hecht Breakdown of academic impact, for papers by James J. Goedert Breakdown of academic impact, for papers by David A. Price Breakdown of academic impact, for papers by Alan Landay Breakdown of academic impact, for papers by Joseph M. McCune Breakdown of academic impact, for papers by Christopher Power Breakdown of academic impact, for papers by Jay A. Levy
Rankless by CCL
2026